DB17906InvestigationalCell transplant therapies
jCell is an human retinal progenitor cell therapy for retinitis pigmentosa.
Resolves to
Compound
What you can answer from here — as of January 09, 2026
Which companies are running trials of Famzeretcel, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account